Reuters Health Report: WTO to rule on landmark tobacco case later on Thursday

WTO to rule on landmark tobacco case later on Thursday

GENEVA (Reuters) - A World Trade Organization adjudication panel will rule on Thursday on a dispute over Australia's tough tobacco packaging rules, widely seen as a test case for public health legislation globally.

AstraZeneca, Merck eye $1 billion boost from cancer drug success

LONDON (Reuters) - AstraZeneca's oncology business received a boost on Wednesday as results of a clinical trial showed its drug Lynparza helped women with ovarian cancer live longer without their disease worsening when given as a first-line treatment.

Array BioPharma gets FDA nod for melanoma combo treatment

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

Aquinox to stop development of lead drug; shares plunge

(Reuters) - Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its main drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, pushing its shares down as much as 85 percent.

Summit plunges 80 percent after muscle-wasting disorder drug fails

(Reuters) - Britain's Summit Therapeutics Plc said on Wednesday that it would stop developing its Duchenne muscular dystrophy (DMD) drug after it failed a mid-stage study, wiping out nearly 80 percent of its market value.

Heat-stable drug could save thousands from post-childbirth bleeding: WHO

LONDON (Reuters) - A new formulation of a drug to prevent excessive bleeding in women after they give birth could save thousands of lives in poorer countries, according to a study co-led by the World Health Organization (WHO).

GBT's drug meets trial goal, investors skeptical of speedy approval

(Reuters) - Global Blood Therapeutics Inc's sickle cell disease treatment met the main goal of a late-stage trial, but scepticism over whether the drug would get an accelerated review from health regulators pushed its shares down 12 percent.

Feeling poorly? The app will see you now

LONDON (Reuters) - London-based start-up Babylon Health said it had put its artificial intelligence technology to the same tests that doctors sit on Wednesday, and showed it could outperform most physicians in assessing symptoms.

Depression may be more severe in elderly people

(Reuters Health) - Elderly people with major depressive disorder may be more likely to suffer severe and persistent symptoms than younger adults with the same mental health diagnosis, a Dutch study suggests.

Paternal smoking linked to miscarriage risk

(Reuters Health) - Would-be fathers may increase their partner's risk of miscarriage by smoking during the pregnancy, or even during the time leading up to conception, a large study from China suggests.

Related Videos

Treadmill tests show polar bears to be efficient walkers

Norway tests tiny electric plane, sees passenger flights by 2025

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here